Meridian Bioscience calls $2.5 million convertibles

New York, May 9 - Meridian Bioscience, Inc. said it has called $2.5 million principal amount of its 7% convertible subordinated debentures due Sept. 1, 2006 for redemption on June 3.

The Cincinnati maker of diagnostic products will pay par plus accrued interest for the securities.

Up to the close of business on June 2, holders can convert the debentures into stock at a price of $16.09 per share. Meridian stock closed at $17.43 on Friday.

Following the call, Meridian will have $2.3 million principal amount of the convertibles outstanding.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.